Please login to the form below

The role of brain health in treating MS

Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the importance of a holistic approach to MS and why digital technology is the future of effective MS care.

Everyone’s neurological reserve, or brain volume, reduces as they get older. Multiple Sclerosis (MS) speeds up this process causing disability and dementia. Relapses cause brain volume shrinkage, which is thought to lead to the symptoms of MS. Rather than treating and reducing relapses, top neurologists like Professor Gavin Giovannoni, key opinion leader and Chair of Neurology at Barts and The London School of Medicine and Dentistry, are looking at the role of general brain health and prescribing earlier, more efficacious treatment to prevent brain damage.

Gavin is pioneering a holistic approach to treating MS. This approach is not just based on prescribing a therapy, but instead looking at the patient’s health holistically. It is about keeping the patient healthy through diet, exercise and other lifestyle changes, as well as through effective medication. He is looking at ways to implement these approaches in the face of opposition from traditionalists, along with how to effectively integrate them with the current healthcare system.

He is also overseeing the development of an app, which will become a platform to bring about substantial changes in the way MS is monitored and treated, giving patients autonomy and doctors easier access to symptoms and results. Here, Blue Latitude Health speaks to him about his work and his hopes for the future of MS treatment.

How does MS affect neurological reserve?

GG: MS greatly reduces neurological reserve capacity causing the brain to age. Everybody will get age-related cognitive impairment but it’s important that your reserves age normally. The idea is to try and shift the attention of the MS community to treat the disease holistically. It’s important not just to focus on reducing relapses, for example, but to think about how to maximise the brain health of their patients so that they can age normally. We need to focus on trying to optimise management early in the course of the disease to improve long-term outcomes. That’s the reason we called our initiative ‘Brain Health’. People need to treat it like an emergency.

Does this mean treating patients with more efficacious drugs at an early stage?

We call this strategy ‘flipping the pyramid’. We offer patients the most effective treatments upfront and that maximises and improves outcomes. With the higher efficacy drugs, we can make patients relapse free. Unfortunately, many neurologists are reluctant to do this, favouring more traditional treatment. One of the problems we have had in the past is this slow adoption of innovation.

What are you doing to solve this problem?

In Australia the MS neurologists know each other very well, they support each other in decision making. In the UK we don’t have a proper MS community. We’re trying to create that with a group called The MS Academy, which is an educational organisation. We’re bringing more people under this umbrella to create an association of British MS healthcare professionals.

DOWNLOAD THE FULL ARTICLE

8th July 2019

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Digital therapeutics and their impact on society
Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?
Blue Latitude Health
Life with multiple myeloma - why I'm a lucky man living the dream
Multiple myeloma patient Bob Munro explains what it's like to live with the rare blood cancer and how his diagnosis led him on the journey of a lifetime – cycling from London to the Arc de Triomphe.
Blue Latitude Health
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can position themselves as leaders at the forefront of these exciting innovations.
Blue Latitude Health
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why.
Blue Latitude Health
Launch Excellence 2020
In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch strategy for improving relationships between the customer and the brand.
Blue Latitude Health
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.
Blue Latitude Health